SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,624,000 | -16.8% | 216,500 | 0.0% | 0.05% | -10.3% |
| Q3 2021 | $1,951,000 | -24.7% | 216,500 | 0.0% | 0.06% | -26.6% |
| Q2 2021 | $2,592,000 | -4.5% | 216,500 | 0.0% | 0.08% | -7.1% |
| Q1 2021 | $2,713,000 | -19.7% | 216,500 | 0.0% | 0.08% | -26.1% |
| Q4 2020 | $3,378,000 | -14.2% | 216,500 | -48.0% | 0.12% | -28.6% |
| Q3 2020 | $3,936,000 | +5.5% | 416,500 | 0.0% | 0.16% | -1.2% |
| Q2 2020 | $3,732,000 | +40.7% | 416,500 | 0.0% | 0.16% | +11.6% |
| Q1 2020 | $2,653,000 | -23.9% | 416,500 | 0.0% | 0.15% | 0.0% |
| Q4 2019 | $3,486,000 | -7.5% | 416,500 | 0.0% | 0.15% | -10.4% |
| Q3 2019 | $3,769,000 | -16.0% | 416,500 | 0.0% | 0.16% | -21.6% |
| Q2 2019 | $4,486,000 | +12.9% | 416,500 | 0.0% | 0.21% | +13.7% |
| Q1 2019 | $3,973,000 | -8.9% | 416,500 | +9.6% | 0.18% | -12.4% |
| Q4 2018 | $4,362,000 | -17.0% | 380,000 | +22.6% | 0.21% | -12.2% |
| Q3 2018 | $5,255,000 | +42.3% | 310,000 | +19.2% | 0.24% | +63.0% |
| Q2 2018 | $3,692,000 | -7.5% | 260,000 | +23.8% | 0.15% | -9.3% |
| Q1 2018 | $3,990,000 | -30.5% | 210,000 | -40.0% | 0.16% | -26.8% |
| Q4 2017 | $5,740,000 | -29.1% | 350,000 | -35.2% | 0.22% | -28.1% |
| Q3 2017 | $8,100,000 | +58.7% | 540,000 | -6.9% | 0.31% | +66.3% |
| Q2 2017 | $5,104,000 | +55.8% | 580,000 | -7.9% | 0.18% | +65.8% |
| Q1 2017 | $3,276,000 | +70.4% | 630,000 | 0.0% | 0.11% | +56.3% |
| Q4 2016 | $1,922,000 | -34.1% | 630,000 | 0.0% | 0.07% | -33.6% |
| Q3 2016 | $2,917,000 | +0.8% | 630,000 | +26.0% | 0.11% | +30.5% |
| Q2 2016 | $2,895,000 | -4.3% | 500,000 | 0.0% | 0.08% | -3.5% |
| Q1 2016 | $3,025,000 | -32.4% | 500,000 | +2.0% | 0.08% | -26.7% |
| Q4 2015 | $4,474,000 | +61.9% | 490,000 | 0.0% | 0.12% | +81.2% |
| Q3 2015 | $2,764,000 | -26.7% | 490,000 | +44.1% | 0.06% | -16.9% |
| Q2 2015 | $3,771,000 | -29.3% | 340,000 | 0.0% | 0.08% | -33.6% |
| Q1 2015 | $5,331,000 | +3.1% | 340,000 | 0.0% | 0.12% | +8.4% |
| Q4 2014 | $5,171,000 | +41.0% | 340,000 | 0.0% | 0.11% | +55.1% |
| Q3 2014 | $3,667,000 | -29.4% | 340,000 | 0.0% | 0.07% | -24.2% |
| Q2 2014 | $5,192,000 | +19.7% | 340,000 | +41.7% | 0.09% | +21.3% |
| Q1 2014 | $4,339,000 | +11.6% | 240,000 | -14.3% | 0.08% | +10.3% |
| Q4 2013 | $3,889,000 | +54.4% | 280,000 | +16.7% | 0.07% | +58.1% |
| Q3 2013 | $2,518,000 | +34.4% | 240,000 | 0.0% | 0.04% | +34.4% |
| Q2 2013 | $1,874,000 | – | 240,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |